# Advisor Meeting — Decisions Needed

These questions are ordered by how directly they block the next validation runs.

## 1. CFA and measurement-model basis

1. Does the forthcoming CFA **confirm the existing eight-factor structure**, or
   does it define a new structure that should replace and re-base the prior work?
2. What exact artifacts will be available: model specification, loadings, factor
   scores, fit statistics, covariance matrix, scoring coefficients, and/or code?
3. Should validators receive fixed respondent-level factor scores, fixed loadings
   with instructions to score them, or a fully specified CFA that they fit
   themselves?
4. Is the measurement model fixed across all three validation stages, including
   generalization, or does any stage reopen it?
5. If a new CFA changes the factor basis, should every prior validation run,
   including GPT-5.5 robustness, be rerun?
6. Which CFA diagnostics and acceptance criteria should be reported before the
   downstream validation begins?
7. Are we comfortable distributing the verified CSV/Parquet derivatives and
   metadata, or should the original `.sav` also travel in each validator package?

## 2. What should “generalization” mean here?

1. What data variation would provide meaningful evidence for this study?
   - a preregistered holdout from the current sample;
   - repeated train/test or cross-validation splits;
   - bootstrap/subsample stability;
   - a separate LoveSmarter wave or external sample;
   - a sequence of these, treated as different strengths of evidence?
2. Is a split of the existing sample genuinely **generalization**, or should it be
   described more narrowly as out-of-sample stability until a new sample exists?
3. Should Stage 3 execute:
   - the original fixed method;
   - the strongest method selected during robustness;
   - each validator's freely chosen method;
   - both a fixed-method and method-free analysis?
4. Should all 13 questions enter Stage 3, or only findings that first replicate and
   pass robustness?
5. What is the success criterion for “generalizes”: same direction, comparable
   effect size, confidence-interval overlap, predictive performance, or a
   question-specific rubric?
6. How should the fixed measurement model be transported to new data? If fixed
   loadings are scored onto a new sample, what invariance checks are required?
7. If no independent wave is currently available, should we implement the
   holdout/resampling machinery now or leave Stage 3 explicitly pending?

## 3. Exploratory “omniverse” versus robustness multiverse

**Working distinction to confirm:** the proposed “omniverse” is an exploratory
**association atlas**: select roughly 100 important, relatively nonredundant
variables; compute all pairwise associations; and rank the strongest relationships.
A multiverse starts with a particular question or finding and reruns it across a
declared set of defensible data-processing and analysis choices to show how much
the conclusion depends on those choices. The first generates leads; the second
stress-tests conclusions.

1. Is that an accurate description of what you mean by **omniverse**, and is
   “omniverse” intended as a formal term or an internal name for the association scan?
2. How will the approximately 100 variables be selected? What makes a variable
   “important,” and does “independent” mean conceptually nonredundant, weakly
   correlated, or statistically independent?
3. Is the deliverable simply a ranked 100 × 100 association matrix, or also a
   network/cluster map, variable families, and a shortlist of candidate findings?
4. Which association measures should be run?
   - Pearson for linear association;
   - Spearman for monotonic association;
   - Chatterjee's xi for more general, potentially nonlinear dependence;
   - more than one as complementary screens?
5. Chatterjee's xi is directional: xi(X, Y) and xi(Y, X) need not agree. For a
   matrix, should both directions be retained, summarized, or symmetrized—and how?
6. A 100-variable scan contains 4,950 unordered pairs. How should we control false
   discoveries and unstable rankings: false-discovery-rate adjustment, permutation
   tests, bootstrap stability, a magnitude threshold, and/or confirmation on a holdout?
7. Will the same observations be used to select the 100 variables, rank their
   associations, and make substantive claims? If so, should the matrix remain
   explicitly exploratory until its leads are tested on held-out or new data?
8. Where should this work sit relative to RRG? Recommended structure:
   - omniverse/association atlas **beside and before** the ladder as lead generation;
   - freeze selected leads and their definitions;
   - validate them through replication/robustness/generalization;
   - use a multiverse as an additional robustness layer for priority findings.
9. Do you want a formal multiverse/specification-curve analysis over plausible
   exclusion rules, missing-data handling, construct definitions, covariates,
   estimators, and outcome codings?
10. Which analytic choices are genuinely defensible alternatives to vary in that
    multiverse, and which construct definitions must remain fixed so the analyses
    still answer the same question?
11. Should multiverse stability contribute to the Stage-2 robustness verdict, or
    be reported as a separate evidence dimension alongside the three-stage ladder?

## 4. Model roster and execution

1. Is the proposed mix of at least one frontier and one open-weights model per
   stage sufficient for the paper's claim?
2. Which exact model versions should be frozen and cited at run time?
3. Do repeated runs of an inexpensive open model add useful evidence about model
   stochasticity, or is one deterministic run per model sufficient?
4. Are API/native-agent differences acceptable as part of the software stack, or
   should execution be standardized more tightly across models?

## 5. Paper scope and reporting

1. Is the primary paper contribution the validation ladder itself, the LoveSmarter
   worked example, or both with equal weight?
2. What minimum empirical completion is needed before drafting/submission: Stages
   1 and 2 across the roster, or a completed Stage 3 as well?
3. Which aggregate results matter most: per-finding validation depth, cross-model
   agreement, reproduction versus convergence rates, method-choice distributions,
   or cost/time comparisons?
4. Should the paper present the GPT-5.5 first-pass divergence and targeted
   refinement as the main worked example of discrepancy localization?
5. Are there funder, data-sharing, authorship, or preregistration constraints that
   should shape the next implementation decisions?

## Decisions to leave the meeting with

- Approved measurement-model basis and artifact list.
- Whether prior validation runs must be rerun.
- Operational definition of Stage 3 data variation.
- Stage 3 method policy and success criteria.
- Meaning and placement of “omniverse” versus multiverse.
- Final model roster and minimum run count.
- Minimum empirical package required for the paper.
